Skip NavigationSkip to Content

mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug Activities

  1. Author:
    Liu, H. F.
    D'Andrade, P.
    Fulmer-Smentek, S.
    Lorenzi, P.
    Kohn, K. W.
    Weinstein, J. N.
    Pommier, Y.
    Reinhold, W. C.
  2. Author Address

    [Liu, Hongfang; Lorenzi, Philip; Kohn, Kurt W.; Weinstein, John N.; Pommier, Yves; Reinhold, William C.] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA. [D'Andrade, Petula; Fulmer-Smentek, Stephanie] Agilent Technol, Santa Clara, CA USA. [D'Andrade, Petula; Fulmer-Smentek, Stephanie] Agilent Technol, Frederick, MD USA. [Lorenzi, Philip; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA. [Liu, Hongfang] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.;Reinhold, WC, NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.;wcr@mail.nih.gov
    1. Year: 2010
    2. Date: May
  1. Journal: Molecular Cancer Therapeutics
    1. 9
    2. 5
    3. Pages: 1080-1091
  2. Type of Article: Article
  3. ISSN: 1535-7163
  1. Abstract:

    As part of the Spotlight on Molecular Profiling series, we present here new profiling studies of mRNA and microRNA expression for the 60 cell lines of the National Cancer Institute (NCI) Developmental Therapeutics program (DTP) drug screen (NCI-60) using the 41,000-probe Agilent Whole Human Genome Oligo Microarray and the 15,000-feature Agilent Human microRNA Microarray V2. The expression levels of similar to 21,000 genes and 723 human microRNAs were measured. These profiling studies include quadruplicate technical replicates for six and eight cell lines for mRNA and microRNA, respectively, and duplicates for the remaining cell lines. The resulting data sets are freely available and searchable online in our CellMiner database. The result indicates high reproducibility for both platforms and an essential biological similarity across the various cell types. The mRNA and microRNA expression levels were integrated with our previously published 1,429-compound database of anticancer activity obtained from the NCI DTP drug screen. Large blocks of both mRNAs and microRNAs were identified with predominately unidirectional correlations to similar to 1,300 drugs, including 121 drugs with known mechanisms of action. The data sets presented here will facilitate the identification of groups of mRNAs, microRNAs, and drugs that potentially affect and interact with one another. Mol Cancer Ther; 9(5); 1080-91. (C) 2010 AACR.

    See More

External Sources

  1. DOI: 10.1158/1535-7163.mct-09-0965
  2. WOS: 000278487500002

Library Notes

  1. Fiscal Year: FY2009-2010
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel